BioPharm International
September 01, 2017
Regulatory Beat
30
9
FDA works with industry on strategies for assuring high-quality regenerative medicines.
September 01, 2017
Ask the Expert
30
9
The differences between the quality control and quality assurance units can be found in their names, according to Siegfried Schmitt, principal consultant at PAREXEL.
September 01, 2017
Features
30
9
Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
September 01, 2017
From the Editor
30
9
Faced with divisive political and social issues, Congress must find a way to reach consensus.
September 01, 2017
Features
30
9
Single-use and single-pass TFF devices are facilitating advances in biopharma manufacturing.
September 01, 2017
Cover Story
30
9
Choosing a suitable material for fill/finish containers begins during the product development stage.
September 01, 2017
Features
30
9
Internet of Things, advanced analytics, and blockchain solutions such as smart contracts promise to give manufacturers more control over products and supply chains.
September 01, 2017
Peer-Reviewed Research
30
9
The control of biologics microbiological impurities, contaminants, and mimetics is evolving.
September 01, 2017
Features
30
9
The authors review how media components modulate the quality of monoclonal antibody products
September 01, 2017
Perspectives on Outsourcing
30
9
Innovation speeds discovery, drives down costs, and improves productivity.
September 01, 2017
Features
30
9
Protecting against microbiological contaminationover the whole manufacturing process grows increasingly important.
September 01, 2017
Issue PDF
30
9
Click the title above to open the BioPharm International September 2017 issue in an interactive PDF format.